Everly Health Launches Comprehensive At-Home Collection Kidney Health Test to Address Chronic Kidney Disease
Everly Health , a digital health company at the forefront of remote diagnostics-driven care, today announced the launch of a comprehensive at-home collection kidney health test for health plans and employers to expand access to prevention, diagnosis, and treatment of chronic kidney disease (CKD).
Everly Health, a digital health company at the forefront of remote diagnostics-driven care, today announced the launch of a comprehensive at-home collection kidney health test for health plans and employers to expand access to prevention, diagnosis, and treatment of chronic kidney disease (CKD).
“Kidney disease affects 37 million adults in the United States but 90% are unaware1 they even have it which makes it a silent killer,” said Dr. Liz Kwo, MD, MPH, MBA, Everly Health Solutions Chief Commercial Officer. “We have an opportunity to significantly change the course of chronic kidney disease in the United States by working to ensure early detection is available to people through the testing they need to protect their kidney health.”
The Everly Health At-Home Collection Kidney Health Test is the combination of an estimated glomerular filtration rate (eGFR) through blood collection, estimating kidney function, and a urinary albumin-to-creatinine ratio (UACR) to assess kidney function through urine collection. Everly Health uses state-of-the-art technology and processes tests at CLIA-certified and CAP-accredited labs to ensure tests meet or exceed the accuracy of traditional laboratory tests. The collection methods used for the Everly Health Kidney Health Test have a correlation of over 98.6% when compared to standard collection methods.
The at-home collection kidney health test aims to lower lifetime costs associated with Chronic Kidney Disease and diabetes by increasing accessibility to testing and satisfying the 2024 KED HEDIS measure. Early detection of kidney disease may reduce Medicare costs associated with CKD by 74% or $63.2 billion based on data collected by Everly Health. As health plans look to boost The Centers for Medicare & Medicaid Services (CMS) Star Ratings and close Healthcare Effectiveness Data and Information Set (HEDIS) measures, Everly Health’s diagnostics-driven remote care model makes it easy to improve health outcomes at much lower costs to both patient and provider.
Health plan administrators can digitally manage the end-to-end progress of preventive screening programs, from monitoring to reporting, seamlessly through Everly Health’s proprietary technology platform. The patient experience is simple: program participants receive their easy-to-use at-home test kit, collect a sample, and mail it back in a pre-paid envelope. Participants receive shipping and processing updates, in addition to the test results and notification of any potential abnormalities, electronically. Participants also receive actionable next steps from a healthcare provider if appropriate.
For more information about the Everly Health At-Home Collection Kidney Health Test visit www.everlyhealthsolutions.com.
About Everly Health
Everly Health’s mission is to transform lives with modern, diagnostics-driven care that meets you where you are. Everly Health is a virtual care provider that uses advanced diagnostics and remote-based care to improve the early detection and prevention of disease. Our solutions provide the clinical and technological framework to facilitate population-scale testing across the healthcare ecosystem. We serve millions of people annually and partner with 100+ enterprise clients to power over 340 programs to close gaps in care and create diagnostics-driven solutions for health plans and employers. We believe that empowering people with convenient access to clinically-actionable testing and remote care has the power to change lives, improve outcomes, and create a healthier world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231005306517/en/